Indian Real Estate Sees 54% Surge In Equity Investments; Reaching USD 11.4 Billion In 2024
Indian real estate attracted record equity investments of USD 11.4 billion in 2024, marking a 54% year-on-year growth.
Demat Accounts Surge By 46 Million In 2024, Reflecting Strong Investor Interest
The total number of demat accounts reached 185.3 million by the end of the year, reflecting growing investor participation in the market.
Explained: HMPV Outbreak, COVID Era To Return? Or A Usual Occurrence
With the Indian and Chinese governments assuring their respective countries of no serious threat, an outbreak of HMPV has raised the eyebrows of people globally.
China Faces Rising Cases Of Human Metapneumovirus Five Years After Covid-19
Five years after Covid-19, China is facing the spread of Human Metapneumovirus (HMPV), a respiratory virus impacting all age groups.
Allahabad High Court Orders Benefits Under PM Garib Kalyan Package For Health Worker’s Family
Covid-19 Health Worker Insurance Scheme benefits be granted to the family of a deceased ward boy, ruling against a narrow interpretation of the scheme.
President Joe Biden Tests Positive For Covid-19
President Joe Biden has tested positive for Covid-19. The President is fully vaccinated and boostedexperiencing mild symptoms.
Budget To Introduce ‘Historic Steps’ Aiming For India To Become 3rd Largest Economy: President Murmu
President Murmu stated, "The pace of reforms will be further accelerated in tune with the aspirations of the people of India for rapid development."
India: First Responder And Voice Of The Global South, Declares President Murmu
Highlighting the government's focus on connectivity, she stated that in the spirit of ‘Sabka Saath, Sabka Vikas’, India is enhancing cooperation with countries in the Indo-Pacific region.
Petition Filed In Supreme Court Seeking Panel Of Medical Experts To Examine Covishield Side Effects
The application also requested that the Center be given instructions on how to recompense those who have died or are seriously injured as a result of the side effects of the corona vaccine they received during COVID 19.
AstraZeneca Acknowledges Its ‘Covishield’ COVID-19 Vaccine Side Effects
Covishield, which was developed by AstraZeneca and Oxford University during the pandemic, was manufactured by the Serum Institute of India
